| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
491,390,000 |
| Market
Cap: |
8.30(B) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$8.08 - $16.46 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : 11.5 |
| Insider 6 Months : 11.5 |
| Insider 3/6 Months : 23 |
|
| Guru Rank Number : 235 |
| Guru Rank Value : 5.2 |
| Guru Occurances : 2 |
|
|
|
|
|
| |
|
Company Profile Elanco Animal Health is an animal health company. Co. groups its products into four principal categories: Companion Animal (CA) Disease Prevention, which includes parasiticides and vaccine products for canines and felines; CA Therapeutics, which includes products for the treatment of pain, osteoarthritis, otitis, cardiovascular and dermatology indications in canines and felines; Food Animal (FA) Future Protein and Health, which includes vaccines, antibiotics, parasiticides and other products used in poultry and aquaculture production; and FA Ruminants and Swine, which includes vaccines, antibiotics, implants, parasiticides and other products used in ruminants and swine production.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
38,100 |
38,100 |
38,100 |
157,300 |
| Total Buy Value |
$617,802 |
$617,802 |
$617,802 |
$2,415,734 |
| Total People Bought |
3 |
3 |
3 |
7 |
| Total Buy Transactions |
3 |
3 |
3 |
12 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-02-08 |
2023-11-07 |
2023-05-09 |
2022-05-09 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Correia De Simas Jose Manuel |
SEE REMARKS |
• – – |
2023-03-02 |
4 |
D |
$11.01 |
$74,879 |
D/D |
(6,801) |
40,945 |
|
- |
|
| Correia De Simas Jose Manuel |
SEE REMARKS |
• – – |
2023-03-02 |
4 |
A |
$0.00 |
$0 |
D/D |
15,107 |
47,746 |
|
- |
|
| Meer James M |
CHIEF ACCOUNTING OFFICER |
• – – |
2023-03-02 |
4 |
D |
$11.01 |
$15,953 |
D/D |
(1,449) |
33,764 |
|
- |
|
| Meer James M |
CHIEF ACCOUNTING OFFICER |
• – – |
2023-03-02 |
4 |
A |
$0.00 |
$0 |
D/D |
8,659 |
35,213 |
|
- |
|
| Urbanek David Alan |
SEE REMARKS |
• – – |
2023-03-02 |
4 |
D |
$11.01 |
$160,647 |
D/D |
(14,591) |
133,294 |
|
- |
|
| Urbanek David Alan |
SEE REMARKS |
• – – |
2023-03-02 |
4 |
A |
$0.00 |
$0 |
D/D |
33,502 |
147,885 |
|
- |
|
| Kinard David S |
SEE REMARKS |
• – – |
2023-03-02 |
4 |
D |
$11.01 |
$136,733 |
D/D |
(12,419) |
129,693 |
|
- |
|
| Kinard David S |
SEE REMARKS |
• – – |
2023-03-02 |
4 |
A |
$0.00 |
$0 |
D/D |
28,571 |
142,112 |
|
- |
|
| Simmons Jeffrey N |
PRESIDENT, CEO AND DIRECTOR |
• • – |
2023-03-02 |
4 |
D |
$11.01 |
$1,518,081 |
D/D |
(137,882) |
1,153,265 |
|
- |
|
| Simmons Jeffrey N |
PRESIDENT, CEO AND DIRECTOR |
• • – |
2023-03-02 |
4 |
A |
$0.00 |
$0 |
D/D |
316,386 |
1,291,147 |
|
- |
|
| Cabral Ramiro Martin |
SEE REMARKS |
• – – |
2023-03-02 |
4 |
D |
$11.01 |
$193,963 |
D/D |
(17,617) |
137,847 |
|
- |
|
| Cabral Ramiro Martin |
SEE REMARKS |
• – – |
2023-03-02 |
4 |
A |
$0.00 |
$0 |
D/D |
40,423 |
155,464 |
|
- |
|
| Young Todd S. |
SEE REMARKS |
• – – |
2023-03-02 |
4 |
D |
$11.01 |
$319,829 |
D/D |
(29,049) |
206,226 |
|
- |
|
| Young Todd S. |
SEE REMARKS |
• – – |
2023-03-02 |
4 |
A |
$0.00 |
$0 |
D/D |
66,655 |
235,275 |
|
- |
|
| Simmons Jeffrey N |
PRESIDENT, CEO AND DIRECTOR |
• • – |
2023-03-02 |
4 |
D |
$11.01 |
$100,730 |
D/D |
(9,149) |
974,761 |
|
- |
|
| Meer James M |
CHIEF ACCOUNTING OFFICER |
• – – |
2023-03-02 |
4 |
D |
$11.01 |
$3,831 |
D/D |
(348) |
26,554 |
|
- |
|
| Kinard David S |
SEE REMARKS |
• – – |
2023-03-02 |
4 |
D |
$11.01 |
$11,109 |
D/D |
(1,009) |
113,541 |
|
- |
|
| Cabral Ramiro Martin |
SEE REMARKS |
• – – |
2023-03-02 |
4 |
D |
$11.01 |
$13,983 |
D/D |
(1,270) |
115,041 |
|
- |
|
| Young Todd S. |
SEE REMARKS |
• – – |
2023-03-02 |
4 |
D |
$11.01 |
$24,222 |
D/D |
(2,200) |
168,620 |
|
- |
|
| Urbanek David Alan |
SEE REMARKS |
• – – |
2023-03-02 |
4 |
D |
$11.01 |
$10,680 |
D/D |
(970) |
114,383 |
|
- |
|
| Simmons Jeffrey N |
PRESIDENT, CEO AND DIRECTOR |
• • – |
2023-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
248,668 |
991,037 |
|
- |
|
| Simmons Jeffrey N |
PRESIDENT, CEO AND DIRECTOR |
• • – |
2023-03-01 |
4 |
D |
$11.26 |
$142,574 |
D/D |
(12,662) |
742,369 |
|
- |
|
| Meer James M |
CHIEF ACCOUNTING OFFICER |
• – – |
2023-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
8,659 |
26,902 |
|
- |
|
| Meer James M |
CHIEF ACCOUNTING OFFICER |
• – – |
2023-03-01 |
4 |
D |
$11.26 |
$7,578 |
D/D |
(673) |
18,243 |
|
- |
|
| Kinard David S |
SEE REMARKS |
• – – |
2023-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
22,270 |
115,130 |
|
- |
|
390 Records found
|
|
Page 4 of 16 |
|
|
3.37 (24.93%) 
